The pandemic forced patients and providers to rely on telemedicine, a change that has had a significant impact on the course of care. Experts discuss what can be accomplished with virtual care and what this means for the potential of medical devices.
Blockchain technology helps support the goal of decentralizing the healthcare sector and providing patients with the information they deserve about their own healthcare data.
Fueled by the need to provide quality care during a global pandemic, healthcare stakeholders are acting quickly to identify new opportunities and overcome challenges.
A global pandemic is still upon us, but that certainly does not mean that healthcare technology innovation is standing still. To help the medical device industry look to the future and prepare, experts from regulation and academia alike are bringing attention to the acceleration and pitfalls of innovation.
As more healthcare activities take place from home, passive continuous monitoring solutions and new technology such as artificial intelligence will be critical to communications between providers and patients. In addition, new solutions that offer overnight monitoring will play a crucial role in helping to fill the gaps, particularly in assessing patient deterioration or changes in health conditions. The pandemic has forever changed the trajectory of healthcare and specifically virtual care.
The omicron variant of the coronavirus has made clear that the impact of the pandemic is far from over, particularly for health systems and hospitals. The ongoing need to limit close contact between providers and patients means technology will continue to play a key role, but with that increased reliance on technology comes the heightened exposure to cyber risks, as well.
With COVID-19 vaccines in mind, Georgia Tech and Emory University researchers have developed a delivery device that could significantly improve vaccine immune response.
Increased use of remote and telehealth programs, networked medical devices, and “smart” product storage come with their own inherent risks.
The center is also hoping to move back into more normal review timelines next year.
Despite current volatility, the industry is anticipated to experience steady, pre-pandemic growth.